IC
ELV icon

IKOS CIF’s Elevance Health ELV Stock Holding History

IKOS CIF’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-5,220
Closed -$727K – 155
2016
Q1 		$727K Buy
+5,220
New +$698K 1.77% 10
2015
Q4 		– Sell
-2,077
Closed -$296K – 207
2015
Q3 		$296K Buy
2,077
+206
+11% +$31K 0.86% 22
2015
Q2 		$313K Sell
1,871
-560
-23% -$89.5K 1.03% 13
2015
Q1 		$378K Sell
2,431
-1,093
-31% -$156K 0.87% 19
2014
Q4 		$446K Buy
+3,524
New +$435K 0.76% 27
2014
Q3 		– Sell
-427
Closed -$46K – 265
2014
Q2 		$46K Buy
+427
New +$44K 0.15% 108
2014
Q1 		– Sell
-182
Closed -$16K – 245
2013
Q4 		$16K Sell
182
-2,047
-92% -$182K 0.04% 207
2013
Q3 		$187K Buy
+2,229
New +$191K 0.23% 112

Other funds holding ELV

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

IKOS CIF's ELV Position: Q2 2016 in Review

IKOS CIF sold out of Elevance Health (ELV) in Q2 2016, closing a stake of 5,220 shares — an estimated $727K sold.

IKOS CIF first reported a position in ELV in Q3 2013 and held it in 8 quarters. The position peaked at $727K in Q1 2016. 759 funds tracked by Wall St. Rank hold ELV as of Q2 2016.

  • IKOS CIF reported no remaining Elevance Health position as of Q2 2016 after selling out during the quarter.
  • IKOS CIF sold 5,220 Elevance Health shares in Q2 2016, an estimated $727K.
  • IKOS CIF first reported a position in Elevance Health in Q3 2013 and held it in 8 quarters.
  • IKOS CIF's Elevance Health position peaked at $727K in Q1 2016.
  • 759 funds tracked by Wall St. Rank held Elevance Health as of Q2 2016.

Based on IKOS CIF's 13F filing for Q2 2016, filed 12 Aug 2016.